Peter Urbanowicz, Managing Director and Co-Head of Alvarez & Marsal's Healthcare Industry Group, recently spoke with Data Book, a Chief Healthcare Executive™ podcast. They discussed the FDA’s shift in priorities to address the issues hospitals are facing, including supply chain issues, device shortages, and the backlog of drug approvals. They also talked about what hospitals are doing in the interim, and how technology can help.
For Peter's thoughts on what hospitals should be doing to adjust, listen to the podcast.
Why Private Equity Works in Value-Based Primary Care
February 2, 2026
Private equity’s influence in value‑based primary care is widely debated, but new evidence shows a different reality. This analysis gives healthcare leaders clarity on where disciplined capital strengthens care models, and where it doesn’t.
The State of Transformation for U.S. Healthcare Providers
January 26, 2026
Market dynamics for health systems are shifting. The most significant driver is the federal Medicaid mandate, which expired at the end of December 2025 and is now pending legislation. This uncertainty is prompting health system leaders to rethink strategy and operations. In this context, we’ll share how other health systems are responding and what these changes mean for organizations like yours.
Strategic Agility for Healthcare Leaders: Building Resilience Amid Disruption
January 12, 2026
The healthcare industry stands at a critical crossroads, grappling with an era of profound disruption and uncertainty. Over the past two decades, the pace of change has accelerated dramatically, reshaping the competitive landscape and challenging the ability of all stakeholders to adapt.
Provider-Sponsored Health Plans: Bridge or Anchor?
December 17, 2025
Provider-sponsored health plans are no longer neutral—they either create enterprise value or drain capital. This analysis gives CFOs and CEOs a clear framework to decide whether to scale, partner, restructure, or exit.
